BEYOND MEAT, INC. (NASDAQ: BYND) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beyond Meat, Inc. Investors of Upcoming Deadline
globenewswire.com
Want to monitor CGEM?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CGEMCullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.